Shares of Amdocs Limited (NASDAQ:DOX – Get Free Report) have received a consensus rating of “Moderate Buy” from the five analysts that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $102.00.
Several analysts recently issued reports on the stock. StockNews.com downgraded shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, October 2nd. Stifel Nicolaus assumed coverage on shares of Amdocs in a research report on Wednesday, October 2nd. They issued a “buy” rating and a $100.00 price target for the company.
Check Out Our Latest Stock Analysis on Amdocs
Amdocs Stock Performance
Amdocs (NASDAQ:DOX – Get Free Report) last posted its quarterly earnings results on Wednesday, August 7th. The technology company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.60 by $0.02. Amdocs had a net margin of 10.21% and a return on equity of 17.89%. The business had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.25 billion. During the same quarter last year, the firm posted $1.41 EPS. Amdocs’s revenue was up 1.1% compared to the same quarter last year. As a group, sell-side analysts anticipate that Amdocs will post 5.67 EPS for the current year.
Amdocs Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Monday, September 30th will be issued a dividend of $0.479 per share. This represents a $1.92 dividend on an annualized basis and a yield of 2.17%. The ex-dividend date of this dividend is Monday, September 30th. Amdocs’s dividend payout ratio is 42.92%.
Hedge Funds Weigh In On Amdocs
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Norwood Financial Corp purchased a new position in shares of Amdocs in the 1st quarter worth about $33,000. Central Pacific Bank Trust Division bought a new stake in Amdocs in the 1st quarter valued at about $53,000. Riverview Trust Co purchased a new stake in Amdocs during the first quarter valued at about $55,000. Quarry LP lifted its holdings in Amdocs by 168.9% during the fourth quarter. Quarry LP now owns 656 shares of the technology company’s stock valued at $58,000 after purchasing an additional 412 shares during the last quarter. Finally, American National Bank purchased a new stake in Amdocs during the second quarter valued at about $76,000. 92.02% of the stock is owned by hedge funds and other institutional investors.
About Amdocs
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Read More
- Five stocks we like better than Amdocs
- What is a Death Cross in Stocks?
- 3 Key Stocks to Ride China’s Stimulus-Driven Growth
- How to Use High Beta Stocks to Maximize Your Investing Profits
- 3 Dividend Growth Stocks Set to Supercharge Your Portfolio
- Insider Trading – What You Need to Know
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.